CD34 and acute myeloid leukemia: Importantly, the fusion protein could profoundly inhibit differentiation and colony formation of primary CD34+ hematopoietic stem/progenitor cells in vitro (Fig. 2h), strongly implicating RUNX1::ERG as an AML driver mutation.